Pediatrics Market By Period of Disease (Long-term Disease and Short-term Disease), Therapeutics (Asthma & Allergies, Cardiology, Gastroenterology, Diabetes, Obesity, Cerebral palsy, Chronic illness, and Others), Treatment (Medication, Immunotherapy, Dietary restrictions, Surgery, and Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Pediatrics Market Size was valued at USD 162.4 billion in 2022 and is poised to grow at a CAGR of 4.5% from 2023-29. Pediatrics is a branch of medicine related to the medical treatment and care of infants and children. According to the Federal Food, Drug, and Cosmetic Act (FD&C Act), Pediatrics patients aged should be 21 or younger at the time of their diagnosis or treatment. Pediatric patients can be categorized as neonates (from birth through the first 28 days of life), infants (29 days to less than 2 years), children (2 years to less than 12 years), adolescents (12 years to less than 22). Some medicines and treatments are specially designed for children others are borrowed from adult applications with the significant change in dosage and other factors. The increasing number of deaths due to various diseases, infections, and malnutrition is driving the growth of the global Pediatrics market. According to UNICEF data, 5 million children under 5 years of age died in 2020 which means 13,800 children under the age of 5 died every day in 2020 due to infectious diseases, including pneumonia, diarrhoea, and malaria along with premature birth and birth-related complications. Moreover, the rise in research and development for new Pediatrics medicines & therapies, and the rise in government support and initiatives will further drive the market. The Pediatrics market is expected to grow significantly due to the prevalence of chronic illness, lower immunity, and a rise in injury-related cases that are more common in children and teenagers. North America is dominating the market based on the region due to rising concerns about child care. Asia Specific regions are likely to register the highest CAGR due to rising premature birth & related complications, malnutrition, rising awareness, and the increasing number of companies investing in Pediatrics medications.

Pediatrics Market Key Developments:
  • In July 2022, The American Academy of Pediatrics and AT&T launched free tools to help families determine their child's cell phone readiness and create healthy media use habits.
  • In Aug 2022, Children's Hospital of Philadelphia (CHOP) announced a new computational platform that will harmonize Pediatrics cancer data to accelerate the pace of drug development for Pediatrics cancer. In May 2022, Summus Global announced a collaboration with Boston children's hospital for virtual care.
  • In Aug 2022, The Leukaemia & Lymphoma Society (LLS) announced that they will work to change the Pediatrics clinical trial model.

Pediatrics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.50%

Largest Market

Asia-Pacific

Fastest Growing Market

North America

Pediatrics Market Dynamics

The growing prevalence of chronic disorders, diarrhea, and injury in children and teenagers is increasing rapidly. These key driving factors are expected to fuel the growth of the global Pediatrics market. According to the Centers for Disease Control and Prevention, 1 in 6 U.S. children aged 2–8 years (17.4%) had a diagnosed mental, behavioral, or developmental disorder. However, the prevalence of autism and attention deficit hyperactivity disorder (ADHD) has continued to rise worldwide. For instance, ADHD, anxiety problems, behavior problems, and depression are the most occurred mental disorders in children. ADHD 9.8% (6.0 million), Anxiety 9.4% (5.8 million), Behavior problems 8.9% (5.5 million), Depression 4.4% (2.7 million) among children age 3-17. So, the demand for pediatric healthcare grew tremendously in 2021.

Pediatrics Market Segmentation

By Period Of Disease

  • Long-term Disease
  • Short-term Disease

By Therapeutics

  • Asthma & Allergies
  • Cardiology
  • Gastroenterology
  • Diabetes
  • Obesity
  • Cerebral palsy
  • Chronic illness
  • Others

By Treatment

  • Medication
  • Immunotherapy
  • Dietary restrictions
  • Surgery
  • Others

Frequently Asked Questions

The pediatrics market is projected to expand at a CAGR of 4.5% during the forecast period

Novartis, Abbott, GlaxoSmithKline, AstraZeneca, Johnson & Johnson, Sanofi LLC, Eli Lilly, Merck and Company, AxcanPharma

North America is the fastest-growing region for pediatrics market

Key Features of the Report

  • The pediatrics market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. Executive Summary
2. Global Pediatrics Market Introduction
2.1. Global Pediatrics Market Taxonomy
2.2. Global Pediatrics Market Definitions
2.2.1. Period of Disease
2.2.2. Therapeutics
2.2.3. Treatment
2.2.4. By Region
3. Global Pediatrics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Pediatrics Market Dynamic Factors - Impact Analysis
3.6. Global Pediatrics Market Competition Landscape
3.7. Epidemiology
4. Global Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Pediatrics Market, By Period of Disease, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Long-term Disease
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Short-term Disease
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Pediatrics Market, By Therapeutics, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Asthma & Allergies
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Cardiology
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Gastroenterology
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Diabetes
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Obesity
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Cerebral palsy
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Chronic illness
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Others
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
7. Global Pediatrics Market, By Treatment, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Medication
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Immunotherapy
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Dietary restrictions
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Surgery
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Pediatrics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Region, 2023 - 2029
9. North America Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Long-term Disease
9.1.2. Short-term Disease
9.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Asthma & Allergies
9.2.2. Cardiology
9.2.3. Gastroenterology
9.2.4. Diabetes
9.2.5. Obesity
9.2.6. Cerebral palsy
9.2.7. Chronic illness
9.2.8. Others
9.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Medication
9.3.2. Immunotherapy
9.3.3. Dietary restrictions
9.3.4. Surgery
9.3.5. Others
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029
9.6. North America Pediatrics Market Dynamics Trends
10. Europe Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Long-term Disease
10.1.2. Short-term Disease
10.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Asthma & Allergies
10.2.2. Cardiology
10.2.3. Gastroenterology
10.2.4. Diabetes
10.2.5. Obesity
10.2.6. Cerebral palsy
10.2.7. Chronic illness
10.2.8. Others
10.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Medication
10.3.2. Immunotherapy
10.3.3. Dietary restrictions
10.3.4. Surgery
10.3.5. Others
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029
10.6. Europe Pediatrics Market Dynamics Trends
11. Asia-Pacific Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Long-term Disease
11.1.2. Short-term Disease
11.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Asthma & Allergies
11.2.2. Cardiology
11.2.3. Gastroenterology
11.2.4. Diabetes
11.2.5. Obesity
11.2.6. Cerebral palsy
11.2.7. Chronic illness
11.2.8. Others
11.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Medication
11.3.2. Immunotherapy
11.3.3. Dietary restrictions
11.3.4. Surgery
11.3.5. Others
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029
11.6. Asia-Pacific Pediatrics Market Dynamics Trends
12. Latin America Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Long-term Disease
12.1.2. Short-term Disease
12.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Asthma & Allergies
12.2.2. Cardiology
12.2.3. Gastroenterology
12.2.4. Diabetes
12.2.5. Obesity
12.2.6. Cerebral palsy
12.2.7. Chronic illness
12.2.8. Others
12.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Medication
12.3.2. Immunotherapy
12.3.3. Dietary restrictions
12.3.4. Surgery
12.3.5. Others
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029
12.6. Latin America Pediatrics Market Dynamics Trends
13. Middle East and Africa Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Long-term Disease
13.1.2. Short-term Disease
13.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Asthma & Allergies
13.2.2. Cardiology
13.2.3. Gastroenterology
13.2.4. Diabetes
13.2.5. Obesity
13.2.6. Cerebral palsy
13.2.7. Chronic illness
13.2.8. Others
13.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Medication
13.3.2. Immunotherapy
13.3.3. Dietary restrictions
13.3.4. Surgery
13.3.5. Others
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. MEA Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029
13.6. MEA Pediatrics Market Dynamics Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Period of Diseases, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Novartis
14.2.2. Abbott
14.2.3. GlaxoSmithKline
14.2.4. AstraZeneca
14.2.5. Johnson & Johnson
14.2.6. Sanofi LLC
14.2.7. Eli Lilly
14.2.8. Merck and Company
14.2.9. AxcanPharma
15. Research Methodology
16. Key Assumptions and Acronyms
  • Novartis
  • Abbott
  • GlaxoSmithKline
  • AstraZeneca
  • Johnson & Johnson
  • Sanofi LLC
  • Eli Lilly
  • Merck and Company
  • AxcanPharma

Adjacent Markets